Inventor · disambiguated record
Anjali Jain
Also filed as: JAIN ANJALI
8 granted patents·7 pending applications·18 citations·filing 2004–2025
81Inventor score
Files withPROMETHEUS LABORATORIES INC6NESTEC SA4CEDARS SINAI MEDICAL CENTER2CEDARS SINAL MEDICAL CT1PREC IBD INC1
Top patents by PatentIndex Score
15 records- 0194US10324088B2Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel diseaseNESTEC SA·Filed 2017·Granted Jun 18, 2019·10 cites·9 claims
- 0290US11162943B2Methods for assessing mucosal healing in Crohn's disease patientsPROMETHEUS LABORATORIES INC·Filed 2018·Granted Nov 2, 2021·4 cites·20 claims
- 0388US2025389717A1Methods for assessing mucosal healing in inflammatory bowel disease patientsPROMETHEUS LABORATORIES INC·Filed 2025·Application pending·0 cites
- 0485US12422432B2Methods for assessing mucosal healing in inflammatory bowel disease patientsPROMETHEUS LABORATORIES INC·Filed 2023·Granted Sep 23, 2025·0 cites·12 claims
- 0579US2024183867A1Indirect homogeneous mobility shift assays for the detection of biologics in patient samplesPROMETHEUS LABORATORIES INC·Filed 2023·Application pending·0 cites
- 0675US11796541B2Methods for assessing mucosal healing in ulcerative colitis disease patientsPROMETHEUS LABORATORIES INC·Filed 2021·Granted Oct 24, 2023·0 cites·20 claims
- 0772US10422807B2Indirect homogeneous mobility shift assays for the detection of biologics in patient samplesPREC IBD INC·Filed 2017·Granted Sep 24, 2019·3 cites·17 claims
- 0869US11846642B2Indirect homogeneous mobility shift assays for the detection of biologics in patient samplesPROMETHEUS LABORATORIES INC·Filed 2019·Granted Dec 19, 2023·0 cites·19 claims
- 0965US9745578B2Targeting microRNA miR-409-3P to treat prostate cancerCEDARS SINAI MEDICAL CENTER·Filed 2015·Granted Aug 29, 2017·1 cites·8 claims
- 1050US9903867B2Methods for predicting and improving the survival of colorectal cancer patientsNESTEC SA·Filed 2015·Granted Feb 27, 2018·0 cites·7 claims
- 1148US2020241006A1Methods for monitoring vedolizumab treatmentPROMETHEUS BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 1246US2007104714A1Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axisCEDARS SINAI MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 1342US2017219605A1Methods for predicting clinical outcomes in subjects afflicted with ulcerative colitisNESTEC SA·Filed 2017·Application pending·0 cites
- 1439US2016356790A1Signaling pathways in tissues from inflammatory bowel disease patientsNESTEC SA·Filed 2016·Application pending·0 cites
- 1531US2014323551A1Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancerCEDARS SINAL MEDICAL CT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anjali Jain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →